Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Content type

Project (12)
Report Summary (7)

Country

Austria (2)
Belgium (6)
Burkina Faso (1)
Czechia (1)
Denmark (4)
Finland (3)
France (8)
Gabon (1)
Germany (9)
Greece (1)
Ireland (1)
Israel (1)
Italy (7)
Luxembourg (2)
Netherlands (9)
Portugal (1)
Senegal (1)
Spain (3)
Sweden (6)
Switzerland (6)
United Kingdom (13)
United States (6)

Advanced search

Search projects and results

Results 1 - 10 of 19
Results/page:
12 > 
Periodic Reporting for period 3 - EbolaMoDRAD (Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics – Sofia ref.: 115843)
The overall aim of EbolaMoDRAD was to develop and deliver rapid and bedside diagnostic tool(s) that will significantly increase our capacity to handle the Ebola Virus Disease (EVD) in West Africa and also future outbreaks. To achieve this, the following specific objectives...
Programme: H2020-EU.3.1.7.13.
Record Number: 228373
Last updated on: 2018-05-10
Ebola Virus: Modern Approaches for developing  bedside Rapid Diagnostics
ID: 115843
Start date: 2015-02-01, End date: 2018-01-31
The current Ebola Virus Disease (EVD) outbreak has caused more than 5000 deaths within a few months in West Africa (Guinea, Sierra Leone and Liberia being the most severely affected countries), including numerous healthcare workers. It is now a serious public health crisis of...
Programme: H2020-EU.3.1.7.13.
Record Number: 209451
Last updated on: 2017-03-27
Periodic Reporting for period 1 - Mofina (Mobile Filovirus Nucleic Acid Test – Sofia ref.: 115848)
We have successfully developed an automated molecular point-of-care (POC) system for the safe, rapid, specific, and sensitive detection of infection with different species/strains of Ebola, and the related virus, Marburg, directly from 'finger-prick' capillary (or venous)...
Programme: H2020-EU.3.1.7.13.
Record Number: 240290
Last updated on: 2018-10-11
Mobile Filovirus Nucleic Acid Test
ID: 115848
Start date: 2015-02-01, End date: 2017-04-30
We are proposing to develop a molecular assay for the safe, rapid, specific and sensitive detection of Ebola Virus Infection in capillary (or venous) blood samples combining ALTONA’s Pan-filo screening IVD test with the existing Alere™ q point of care molecular diagnostics...
Programme: H2020-EU.3.1.7.13.
Record Number: 209448
Last updated on: 2017-06-01
Periodic Reporting for period 2 - EBODAC (Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.)
The Ebola virus disease (EVD) epidemic has infected more than 28.000 people and killed more than 11.000 from March 2014 to December 2015, the vast majority of them in 3 West African countries: Guinea, Liberia and Sierra Leone (WHO Ebola Situation Report June 10, 2016). No...
Programme: H2020-EU.3.1.7.13.
Record Number: 232106
Last updated on: 2018-06-22
Periodic Reporting for period 2 - EBOVAC2 (Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II)
Combining the expertise and capabilities of global research institutions, non-government organizations and the pharmaceutical industry has been critical to help address the Ebola public health challenge.The Ebola vaccine projects - EBOVAC1, EBOVAC2, EBODAC and EBOMAN - are a...
Programme: H2020-EU.3.1.7.13.
Record Number: 230029
Last updated on: 2018-05-22
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861
ID: 115861
Start date: 2014-12-01, End date: 2019-11-30
The main objective therefore of EBOVAC 2 is to provide extensive and robust data on the safety, immunogenicity and efficacy of the Ad26.ZEBOV and MVA-BN-Filo vaccine.This will be done by:1. Carrying out translational studies to link vaccine elicited immune responses in humans...
Programme: H2020-EU.3.1.7.13.
Record Number: 209445
Last updated on: 2017-07-28
Communication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847
ID: 115847
Start date: 2014-12-01, End date: 2019-11-30
Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.The EBODAC consortium consists of 4 partners: Janssen (EFPIA), London School of Hygiene and Tropical Medicine (LSHTM), World Vision of Ireland and Grameen Foundation . These partners...
Programme: H2020-EU.3.1.7.13.
Record Number: 209447
Last updated on: 2017-03-27
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854
ID: 115854
Start date: 2014-12-01, End date: 2019-11-30
The overall aim of the EBOVAC programme is to assess the safety and efficacy of a novel prime boost prophylactic vaccine regimen against Ebola Virus Disease (EVD), which has been 100% effective in preclinical studies. This will be done via phase I, II and III trials carried...
Programme: H2020-EU.3.1.7.13.
Record Number: 209452
Last updated on: 2017-03-27
Periodic Reporting for period 2 - VSV-EBOVAC (Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV)
"The overall objective of VSV-EBOVAC is to comprehensively characterize the immune and molecular signatures of immune responses elicited in humans by rVSV-ZEBOV, a promising Ebola vaccine candidate based on the replication-competent recombinant vesicular stomatitis virus (VSV)...
Programme: H2020-EU.3.1.7.13.
Record Number: 230741
Last updated on: 2018-05-31
12 > 
List retrieved on: 2018-12-10
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top